Literature DB >> 24986374

Prognostic value of worsening renal function in outpatients with chronic heart failure.

Rodrigo Pimentel1, Marta Couto1, Olga Laszczyńska2, Fernando Friões1, Paulo Bettencourt1, Ana Azevedo3.   

Abstract

INTRODUCTION AND
OBJECTIVES: Renal function impairment predicts poor survival in heart failure. Attention has recently shifted to worsening renal function, based mostly on serum creatinine and estimated glomerular filtration rate. We assessed the prognostic effect of worsening renal function in ambulatory heart failure patients.
METHODS: Data from 306 ambulatory patients were abstracted from medical files. Worsening renal function was based on the change in estimated glomerular filtration rate, serum creatinine and urea within 6 months of referral. Prognosis was assessed by the composite endpoint all-cause death or heart failure hospitalization, censored at 2 years. Hazard ratios were estimated for worsening renal function, adjusted for sex, age, diabetes, New York Heart Association class, left ventricular systolic dysfunction, medications and baseline renal function.
RESULTS: The agreement among definitions was fair, with kappa coefficients generally not surpassing 0.5. Worsening renal function was associated with poor outcome with adjusted hazard ratios (95% confidence interval) of 3.2 (1.8-5.9) for an increase of serum creatinine >0.3mg/dl; 2.2 (1.3-3.7) for an increase in serum urea >20mg/dl and 1.9 (1.1-3.3) for a decrease in estimated glomerular filtration rate >20%, independent of baseline renal function. The 2-year risk of death/heart failure hospitalization was approximately 50% in patients with an increase in serum creatinine or in serum urea; this positive predictive value was higher than for decreasing estimated glomerular filtration rate.
CONCLUSIONS: In conclusion, worsening renal function was significantly associated with a worse outcome. Different definitions identified different patients at risk and increasing creatinine/urea performed better than decreasing estimated glomerular filtration rate.
Copyright © 2014 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardio-renal syndrome; Heart failure; Prognosis; Worsening renal function

Mesh:

Year:  2014        PMID: 24986374     DOI: 10.1016/j.ejim.2014.06.002

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  5 in total

1.  An Appraisal of Biomarker-Based Risk-Scoring Models in Chronic Heart Failure: Which One Is Best?

Authors:  Barbara S Doumouras; Douglas S Lee; Wayne C Levy; Ana C Alba
Journal:  Curr Heart Fail Rep       Date:  2018-02

2.  Predictors and Prognostic Value of Worsening Renal Function During Admission in HFpEF Versus HFrEF: Data From the KorAHF (Korean Acute Heart Failure) Registry.

Authors:  Jeehoon Kang; Jin Joo Park; Young-Jin Cho; Il-Young Oh; Hyun-Ah Park; Sang Eun Lee; Min-Seok Kim; Hyun-Jai Cho; Hae-Young Lee; Jin Oh Choi; Kyung-Kuk Hwang; Kye Hun Kim; Byung-Su Yoo; Seok-Min Kang; Sang Hong Baek; Eun-Seok Jeon; Jae-Joong Kim; Myeong-Chan Cho; Shung Chull Chae; Byung-Hee Oh; Dong-Ju Choi
Journal:  J Am Heart Assoc       Date:  2018-03-13       Impact factor: 5.501

3.  Electro-echocardiographic Indices to Predict Cardiac Resynchronization Therapy Non-response on Non-ischemic Cardiomyopathy.

Authors:  Ziqing Yu; Xueying Chen; Fei Han; Shengmei Qin; Minghui Li; Yuan Wu; Yangang Su; Junbo Ge
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

4.  Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: A UK national study.

Authors:  Claire A Lawson; J M Testani; M Mamas; K Damman; P W Jones; L Teece; U T Kadam
Journal:  Int J Cardiol       Date:  2018-09-15       Impact factor: 4.164

Review 5.  Renal dysfunction in cardiovascular diseases and its consequences.

Authors:  Giacomo Deferrari; Adriano Cipriani; Edoardo La Porta
Journal:  J Nephrol       Date:  2020-09-01       Impact factor: 3.902

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.